CNY 12.94
(-0.23%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 195.21 Million CNY | -2.34% |
2022 | 199.89 Million CNY | 5.69% |
2021 | 189.13 Million CNY | 4.94% |
2020 | 180.22 Million CNY | -6.22% |
2019 | 192.19 Million CNY | -3.14% |
2018 | 198.41 Million CNY | 8.93% |
2017 | 182.15 Million CNY | -24.03% |
2016 | 239.78 Million CNY | 31.56% |
2015 | 182.26 Million CNY | -4.61% |
2014 | 191.06 Million CNY | -27.7% |
2013 | 264.25 Million CNY | 27.83% |
2012 | 206.72 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 244.2 Million CNY | 25.09% |
2024 Q3 | 256.04 Million CNY | 11.63% |
2024 Q2 | 229.36 Million CNY | -6.08% |
2023 FY | 195.21 Million CNY | -2.34% |
2023 Q3 | 238.91 Million CNY | 22.67% |
2023 Q2 | 194.75 Million CNY | -17.43% |
2023 Q1 | 235.86 Million CNY | 18.0% |
2023 Q4 | 195.21 Million CNY | -18.29% |
2022 Q2 | 164.3 Million CNY | -7.39% |
2022 Q1 | 177.41 Million CNY | -6.19% |
2022 Q3 | 263.91 Million CNY | 60.62% |
2022 FY | 199.89 Million CNY | 5.69% |
2022 Q4 | 199.89 Million CNY | -24.26% |
2021 Q1 | 221.14 Million CNY | 22.7% |
2021 Q3 | 215.63 Million CNY | 18.64% |
2021 Q2 | 181.75 Million CNY | -17.81% |
2021 Q4 | 189.13 Million CNY | -12.29% |
2021 FY | 189.13 Million CNY | 4.94% |
2020 Q2 | 189.08 Million CNY | -1.75% |
2020 Q3 | 185.38 Million CNY | -1.96% |
2020 FY | 180.22 Million CNY | -6.22% |
2020 Q4 | 180.22 Million CNY | -2.78% |
2020 Q1 | 192.46 Million CNY | 0.14% |
2019 Q3 | 180.96 Million CNY | 1.52% |
2019 Q2 | 178.25 Million CNY | -18.17% |
2019 Q4 | 192.19 Million CNY | 6.2% |
2019 FY | 192.19 Million CNY | -3.14% |
2019 Q1 | 217.82 Million CNY | 9.78% |
2018 Q2 | 178.63 Million CNY | 11.85% |
2018 FY | 198.41 Million CNY | 8.93% |
2018 Q4 | 198.41 Million CNY | -0.27% |
2018 Q3 | 198.94 Million CNY | 11.37% |
2018 Q1 | 159.7 Million CNY | -12.32% |
2017 Q3 | 174.35 Million CNY | 0.4% |
2017 Q4 | 182.15 Million CNY | 4.48% |
2017 Q1 | 187.15 Million CNY | -21.95% |
2017 FY | 182.15 Million CNY | -24.03% |
2017 Q2 | 173.65 Million CNY | -7.21% |
2016 Q4 | 239.78 Million CNY | 0.0% |
2016 Q2 | 142.39 Million CNY | 0.0% |
2016 Q1 | - CNY | 0.0% |
2016 FY | 239.78 Million CNY | 31.56% |
2015 FY | 182.26 Million CNY | -4.61% |
2014 FY | 191.06 Million CNY | -27.7% |
2013 FY | 264.25 Million CNY | 27.83% |
2012 FY | 206.72 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Liuzhou Liangmianzhen Co., Ltd. | 505.75 Million CNY | 61.4% |
Shanghai Jahwa United Co., Ltd. | 3.76 Billion CNY | 94.814% |
Henan Rebecca Hair Products Co., Ltd. | 2.53 Billion CNY | 92.292% |
Perfect Group Corp., Ltd | 765.94 Million CNY | 74.513% |
RUNBEN BIOTECHNOLOGY | 97.61 Million CNY | -99.994% |
Proya Cosmetics Co.,Ltd. | 2.91 Billion CNY | 93.306% |
Shanghai Flyco Electrical Appliance Co., Ltd. | 806.72 Million CNY | 75.801% |
Guangdong Marubi Biotechnology Co., Ltd. | 1.02 Billion CNY | 81.029% |
Hangzhou Haoyue Personal Care Co., Ltd | 1.42 Billion CNY | 86.342% |